adalimumab
Generic: adalimumab-fkjp
Labeler: biocon biologics incDrug Facts
Product Profile
Brand Name
adalimumab
Generic Name
adalimumab-fkjp
Labeler
biocon biologics inc
Dosage Form
KIT
Manufacturer
Identifiers & Regulatory
Product NDC
83257-021
Product ID
83257-021_ce598802-5148-0115-bd4c-fea7dd51fb90
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761154
Listing Expiration
2027-12-31
Marketing Start
2024-04-15
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
83257021
Hyphenated Format
83257-021
Supplemental Identifiers
RxCUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adalimumab (source: ndc)
Generic Name
adalimumab-fkjp (source: ndc)
Application Number
BLA761154 (source: ndc)
Resolved Composition
Strengths
- 40 mg/0.8 ml
- 20 mg/0.4 ml
- 1 ml
Packaging
- 2 TRAY in 1 KIT (83257-021-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET
Packages (1)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "ce598802-5148-0115-bd4c-fea7dd51fb90", "openfda": {"rxcui": ["797544", "2640404", "2640412", "2640417"], "spl_set_id": ["5cde907d-6747-0e62-db25-1718ee717fe7"], "manufacturer_name": ["Biocon Biologics Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 KIT (83257-021-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET", "package_ndc": "83257-021-42", "marketing_start_date": "20240415"}], "brand_name": "Adalimumab", "product_id": "83257-021_ce598802-5148-0115-bd4c-fea7dd51fb90", "dosage_form": "KIT", "product_ndc": "83257-021", "generic_name": "adalimumab-fkjp", "labeler_name": "Biocon Biologics Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adalimumab", "application_number": "BLA761154", "marketing_category": "BLA", "marketing_start_date": "20240415", "listing_expiration_date": "20271231"}